Embed Size (px)
Citation preview
Opportunity for Choice in the National Down’s Syndrome Screening Programme (NDSSP)
Presented by:
Nancy L. Chung
The partners
The NHS FASP
• Established in 1996.
• National lead for antenatal screening for chromosomal and structural abnormalities.
– Down’s syndrome screening– 18+0-20+6 week ultrasound scan
• Accessibility• Equality• Quality• Choice
Down’s syndrome screening
Commissioning tool
Women with singleton pregnancy at 10 weeks
Spontaneous miscarriage before screening offered
Offered screening
Spontaneous miscarriage
Spontaneous miscarriage
Accept screening test
Decline screening test
High risk result
Low risk result
Down’s birth
Other birth
Go to 1
Accept CVS or amniocentesis
Decline CVS or amniocentesis
Positive test
Negative test
No procedural related miscarriage
Procedural related miscarriage
Go to 1
Accept TOP
Decline TOP
Go to 1
TOP
Live Birth
1
Go to 1
10-14/16 weeks
10 weeks To term
NHS FASP benefits
PenTAG benefits
(Peninsula Collaborations for Leadership in Applied Health Research and Care)
Associate benefits
Health economics
Modelling
UK health care system
Conclusion
• Project is now in the pilot phase.
• Overwhelmingly positive response.
• Interest in sharing the tool and transfer to other UK screening programmes.
• National and international interest in the project.
• Setting FASP as an innovator.
Nancy L. Chung, BSc (Kinesiology), MBA, MHSA
NHS FASP Innovation CentreRennes DriveUniversity of ExeterExeterDevonEX4 3AG
Thank you
http://fetalanomaly.screening.nhs.uk/
http://sites.pcmd.ac.uk/pentag/main.php?c=welcome
